Skip to main content

Table 1 Characteristics of the intervention and the control group before and after policy implementation

From: Implementation of the Chronic Disease Care System and its association with health care costs and continuity of care in Korean adults with type 2 diabetes mellitus

 

Pre-implementation period

Post-implementation period

 

Control group

Intervention group

Control group

Intervention group

Total

14,191

(80.7)

3388

(19.3)

13,036

(80.4)

3184

(19.6)

Age

 20–29

144

(1.0)

26

(0.8)

94

(0.7)

15

(0.5)

 30–39

928

(6.5)

193

(5.7)

643

(4.9)

112

(3.5)

 40–49

3699

(26.1)

883

(26.1)

2856

(21.9)

651

(20.4)

 50–59

7183

(50.6)

1780

(52.5)

6238

(47.9)

1580

(49.6)

 60–64

2237

(15.8)

506

(14.9)

3205

(24.6)

826

(25.9)

Sex

 Male

8911

(62.8)

2063

(60.9)

8252

(63.3)

1935

(60.8)

 Female

5280

(37.2)

1325

(39.1)

4784

(36.7)

1249

(39.2)

Income

 Low

4241

(29.9)

1097

(32.4)

3536

(27.1)

976

(30.7)

 Middle

4033

(28.4)

1055

(31.1)

3544

(27.2)

967

(30.4)

 High

5219

(36.8)

1230

(36.3)

5208

(40.0)

1239

(38.9)

NHI type

 Occupational

8122

(57.2)

2016

(59.5)

7725

(59.3)

1985

(62.3)

 Regional

5371

(37.8)

1366

(40.3)

4563

(35.0)

1197

(37.6)

Region

 Seoul

2670

(18.8)

562

(16.6)

2402

(18.4)

521

(16.4)

 Metropolitan

3782

(26.7)

1006

(29.7)

3423

(26.3)

963

(30.2)

 Rural

7739

(54.5)

1820

(53.7)

7211

(55.3)

1700

(53.4)

Charlson Comorbidity Index

 0

711.0

(5.0)

149

(4.4)

568.0

(4.4)

115.0

(3.6)

 1

6765

(47.7)

1657

(48.9)

6187

(47.5)

1604

(50.4)

 2

2573

(18.1)

664

(19.6)

2363

(18.1)

611

(19.2)

 3+

4142

(29.2)

918

(27.1)

3918.0

(30.1)

854.0

(26.8)

Disability

 No

12,832

(90.4)

3139

(92.7)

11,684

(89.6)

2940

(92.3)

 Yes

1359

(9.6)

249

(7.3)

1352

(10.4)

244

(7.7)

Medication

        

 None

546

(3.8)

39

(1.2)

476

(3.7)

30

(0.9)

 Insulin only

183

(1.3)

45

(1.3)

163

(1.3)

36

(1.1)

 Hypoglycemic agent only

12,530

(88.3)

3147

(92.9)

11,544

(88.6)

2964

(93.1)

 Insulin & hypoglycemic agent

932

(6.6)

157

(4.6)

853

(6.5)

154

(4.8)

Complication

 No

8258

(58.2)

2050

(60.5)

7626

(58.5)

1966

(61.7)

 Yes

5933

(41.8)

1338

(39.5)

5410

(41.5)

1218

(38.3)

  1. *NHI=National Health Insurance
  2. Hypoglycemic agents include sulfonylureas, metformin, alpha glucosidase inhibitors, and thiazolidinedione